Management Strategies for Congestive Heart Failure in Chronic Kidney Disease: Narrative Review

Area of Science:

• Cardiology
• Nephrology
• Internal Medicine

Background:

• Heart failure (HF) affects millions globally and often coexists with chronic kidney disease (CKD).
• Cardiovascular disease is a leading cause of death in CKD patients, exacerbating morbidity and mortality.
• Declining kidney function significantly increases the risk and worsens the prognosis of HF in CKD patients.

Purpose of the Study:

• To provide healthcare professionals with evidence-based strategies for identifying and managing the comorbidity of HF in CKD patients.
• To synthesize recent findings on risk stratification, diagnostic modalities, and individualized treatment for HF in CKD.
• To enhance volume management and optimize patient outcomes, particularly for those undergoing renal replacement therapy.

Main Methods:

• This narrative review synthesizes recent findings from medical literature.
• It addresses pathogenic mechanisms, diagnostic approaches, pharmacological treatments, and modifications in dialytic therapy.
• Focus is placed on evidence-based strategies for risk stratification and individualized management.

Main Results:

• The review highlights the complex interplay between HF and CKD, emphasizing the negative impact on patient prognosis.
• It underscores the importance of tailored management strategies, including volume control and optimized therapies.
• Specific attention is given to patients undergoing renal replacement therapy.

Conclusions:

• Effective management of HF in CKD patients is crucial for reducing hospitalizations and mortality.
• Individualized treatment approaches, considering pathogenic mechanisms and diagnostic findings, are essential.
• Optimizing care for CKD patients with HF can significantly improve quality of life and long-term outcomes.